| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Award | $801,331 | +3,294 | +12% | $243.27 | 30,240 | 09 Feb 2022 | Direct | |
| holding | LLY | Common Stock | 514 | 09 Feb 2022 | 401(k) | ||||||
| holding | LLY | Common Stock | 128 | 09 Feb 2022 | by partner | F1 | |||||
| holding | LLY | Common Stock | 2,675 | 09 Feb 2022 | 401(k) - by partner | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Award | $0 | +2,102 | $0.000000 | 2,102 | 09 Feb 2022 | Common Stock | 2,102 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Reporting person disclaims beneficial ownership of these shares. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |